Prof. Paul Stupple is a Professor of Medicinal Chemistry at Monash University, Australia, with over 20 years' experience in pharmaceutical industry and academia. He holds leadership roles at Canthera Discovery and manages the Australian Translational Medicinal Chemistry Facility. His expertise lies in small molecule drug discovery, particularly targeting cancer therapies and epigenetic regulators. Affiliations: Monash University, Faculty of Pharmacy and Pharmaceutical Sciences Canthera Discovery (Director, Medicinal Chemistry) Education: BA and DPhil in Chemistry from the University of Oxford (1992–1999). Early career at Pfizer as a medicinal chemistry leader, delivering 6 clinical candidates. Key contributions include: Licensing deals with Merck (2016) and Pfizer (2018) for preclinical projects Leading the Cancer Therapeutics CRC's medicinal chemistry program Research Interests: Small molecule drug discovery focused on histone acetyltransferase inhibitors, cancer therapeutics, and epigenetic modulation. Notable projects include development of KAT6A/B inhibitors for ER+ breast cancer and STING agonists for immunotherapy. Grants/Projects: Principal Investigator for major initiatives like MedChem Australia (2023–2028) and drug target identification platforms. Collaborates widely with institutions like WEHI and University of Sydney. Over 28 peer-reviewed publications spanning 1997–2025. Labs/Teams: Oversees the Australian Translational Medicinal Chemistry Facility, a key resource for drug discovery in Australia.
Prof. Dr. Philipp Heretsch is a Professor and Executive Director at the Institute of Organic Chemistry, Faculty of Natural Sciences, Leibniz University Hannover. He leads the Natural Product Synthesis research group and holds key roles in academic governance, including Deputy Coordinator for Exchange Programmes and representation on various examination and curriculum boards. Research Interests: His research focuses on the synthesis of complex natural products, particularly terpenes and alkaloids, using biosynthesis-inspired strategies. He develops novel carbon–carbon bond manipulation techniques and rearrangement cascades. A significant emphasis is placed on the biological activity of synthesized compounds. He also pioneers the development of continuous flow reactor systems for the selective transformation of sensitive and short-lived chemical species. Publication Trends: His recent publications (2020–2025) demonstrate a strong focus on biogenesis-inspired total synthesis of highly complex natural products (e.g., canataxpropellane, swinhoeisterol), the application of radical-polar crossover and rearrangement strategies, and the innovative use of flow chemistry for scalable and efficient synthesis of both natural products and functional molecules like odorants and ferrocenyl compounds. Scientific Awards: ADUC Prize of the GDCh (2018) DECHEMA Young Scientist Prize for Natural Product Research (2020) ORCHEM Prize for Young Scientists of the Liebig Association for Organic Chemistry of the GDCh Advising and Grants: While specific students are not listed, he leads an active research group. His work is supported by significant external funding, including an ERC Consolidator Grant for the project "RadCrossSyn" and support from the DFG Heisenberg Program, which facilitated his move to Leibniz University Hannover in 2021. Labs and Teams: He heads the Natural Product Synthesis research group at the Institute of Organic Chemistry, Leibniz University Hannover. His research group, often referred to as the "Heretsch group," is dedicated to developing novel synthetic methodologies and applying them to the synthesis of biologically relevant natural products.
Prof. Dr. Oliver Reiser is a full Professor at the Institute of Organic Chemistry within the Faculty of Chemistry and Pharmacy at the University of Regensburg. His research group focuses on cutting-edge developments in organic synthesis, particularly in the areas of photocatalysis and visible light chemistry. He leads the Collaborative Research Centre CRC 325 on "Assembly Controlled Chemical Photocatalysis," which aims to develop new frontiers in photocatalysis for organic synthesis through designed control of catalyst-substrate interactions. University of Hamburg (PhD, 1989) IBM Research Center (Postdoc) Harvard University (Postdoc) University of Göttingen (Habilitation, 1995) Prof. Reiser's research spans multiple interconnected fields with a strong emphasis on sustainable chemistry. His group extensively utilizes modern techniques for organic synthesis including flow reactors, microwaves, and high-pressure systems. The primary research thrusts include catalysis (both metal and organocatalysts), unnatural amino acids and peptide foldamers, and natural product synthesis. His work on visible light photocatalysis has been particularly influential, with numerous publications in high-impact journals like Angewandte Chemie and Nature Catalysis. The group's research integrates experimental, spectroscopic, and computational techniques to analyze catalyst-substrate interactions for more rational design of photochemical reactions. Analysis of Prof. Reiser's recent publications (2023-2025) reveals a strong focus on copper-based photocatalysis, sustainable chemistry using earth-abundant metals, and innovative approaches to heterocycle synthesis. His work demonstrates a clear trend toward developing more efficient and environmentally friendly catalytic processes, with particular emphasis on visible light activation, catalyst immobilization for recyclability, and applications in medicinal chemistry. The research spans from fundamental mechanistic studies to practical applications in synthesis. German Academic Scholarship Foundation Minerva Foundation NATO Fellowship German Research Foundation Support Karl Winnacker Foundation Prof. Reiser has supervised numerous doctoral students, with recent PhD theses focusing on copper photoredox catalysis, magnetic nanoparticle-supported catalysts, and the synthesis of bioactive compounds. His research is supported by multiple collaborative projects, including the Collaborative Research Centre CRC 325, and involves extensive national and international collaborations with institutions such as the University of Kansas, the National Institute of Chemistry in Pune, the Institut Chimie de Coordination du CNRS in Toulouse, and the University of Zaragoza. The group maintains strong ties with pharmaceutical research through collaborations with Prof. A. Beck-Sickinger in Leipzig on neuropeptide ligands. The research group operates well-equipped laboratories with capabilities for advanced organic synthesis and characterization. They have developed specialized expertise in flow chemistry, high-pressure techniques, and magnetic nanoparticle-based catalyst systems. The CRC 325 initiative has provided significant infrastructure for collaborative research in photocatalysis, bringing together multiple research groups with complementary expertise in organic synthesis, spectroscopy, and computational chemistry.
Mark Wallace is a Professor of Chemistry at King's College London, affiliated with the Department of Chemistry and the Faculty of Natural, Mathematical & Engineering Sciences. He holds a Royal Society University Research Fellowship (2005–2016) and has been a lecturer at Oxford University before joining King's in 2016. His research focuses on membrane protein function and artificial membrane mimics, combining optical microscopy and nanotechnology. He earned a PhD from the University of Cambridge (2002) and postdoctoral training at Stanford University and the National Institute for Medical Research. Key research interests include membrane protein dynamics, lipid bilayer engineering, and single-molecule imaging. He has pioneered techniques like droplet interface bilayers and interferometric scattering microscopy. His work has led to patents and applications in molecular sensing and medical research. Awards include the 2002 Gregorio Weber Prize and the 2015 RSC Norman Heatley Award. He is actively involved in public outreach, including video podcasts and educational competitions. Recent publications emphasize artificial ion channels, nanoparticle formation monitoring, and mitochondrial protein dynamics. His lab collaborates with institutions like the London Centre for Nanotechnology and the Rosalind Franklin Institute. Over 30 students and researchers have been mentored, with active grants from EPSRC, Wellcome Trust, and BBSRC.
Amy E. Fraley is an Assistant Professor at ETH Zürich, Department of Chemistry and Applied Biosciences, and leads the Medicinal Chemistry Research Group. Her cross-disciplinary work bridges natural products biosynthesis, pharmaceutical sciences, and environmental sustainability through enzymatic chemistry and biotechnology. BSc in Chemistry, Millersville University of Pennsylvania (2014) PhD in Medicinal Chemistry, University of Michigan College of Pharmacy (2019) Postdoctoral work at ETH Zürich Institute of Microbiology under Prof. Jörn Piel Her research focuses on harnessing biosynthetic enzymes (e.g., halogenases, monooxygenases, Diels-Alderases) to create sustainable bioactive metabolites. She explores natural product biosynthesis in fungi and marine bacteria, targeting disease mechanisms and green chemistry applications. Recent work includes metagenomic studies of Lake Chilika microbial mats and polyketide synthase engineering. Notable scientific awards include the 2024 JSP Fellow at Bürgenstock Conference, 2018 Rackham Predoctoral Fellowship, and multiple University of Michigan honors. Her group secured funding from the ETH4D Doctoral Mentorship Grant and Messerli Foundation . Collaborations span structural biology, synthetic chemistry, and microbiology, with key contributions to flavoenzyme characterization and bioactive compound libraries . The lab emphasizes interdisciplinary training and innovation in biocatalytic tools for organic synthesis.
Professor George Britovsek (FRSC) is a leading figure in catalysis and sustainable carbon management at Imperial College London . As Director of the MRes in Catalysis & Engineering and Head of Teaching in Inorganic Chemistry, he bridges academic leadership with cutting-edge research. His work focuses on transition metal complexes for converting ethylene , alkanes , biomass , and CO₂ into valuable chemicals and fuels through industrial collaborations. Education : M.Sc. (Technical University of Aachen, 1990), Ph.D. (Aachen, 1993) under Prof. W. Keim Postdoctoral Training : University of Tasmania (1994-1996), Imperial College London (1996-2000) His research interests span: Selective oxidation of alkanes using bio-inspired iron complexes Alkene conversions to functional polymers via novel catalysts CO₂ valorization into polymers and cyclic carbonates Biomass-derived feedstocks for chemical synthesis Recent catalysis trends highlight his work on: Designing Fe-N/C catalysts for epoxidation Developing PN3P pincer ligands for H₂ activation Creating degradable polyethylene via iron-catalyzed chain growth Modeling alternating α-olefin distributions in chromium systems Awards : Fellow of the Royal Society of Chemistry (FRSC) Students & Collaborators actively engage in: Photocatalytic polymer degradation Electrocatalytic CO₂ conversion Functionalized polymeric materials 3D-printed catalytic scaffolds His Britovsek Research Group operates at the Molecular Sciences Research Hub, White City Campus, advancing both homogeneous and heterogeneous catalysis through experimental and computational approaches.
Tarik Abou-Chadi is a Professor in European Union and Comparative European Politics at the University of Oxford's Department of Politics and International Relations, and a Professorial Fellow at Nuffield College. He holds a PhD from Humboldt University Berlin (2015). His research focuses on elections, political parties, and the transformation of democratic representation in post-industrial societies. Key affiliations include the Government and Politics Network, Comparative Politics and Government, and leadership of the Swiss National Science Foundation-funded project on 'Social Status and the Transformation of Electoral Behavior in Western Europe'. He previously served as Assistant Professor at the University of Zurich before joining Oxford. His work appears in top journals like the American Political Science Review and World Politics. Awards include the Henrik Enderlein Prize (2022) and inclusion in Capital magazine's 'Top 40 under 40' (2022). He advises four doctoral students and actively contributes to media commentary on European political trends through outlets like The Economist. Research interests emphasize far-right dynamics, voter behavior, and party strategy in Western Europe. His recent analyses address gendered political preferences among youth, climate policy acceptance, and the electoral consequences of mainstream parties adopting radical-right policies.
Dr. Rodney Weber is a Professor in the School of Earth & Atmospheric Sciences at Georgia Institute of Technology, part of the College of Sciences. His research focuses on atmospheric aerosols, urban air quality, and particle formation mechanisms. He holds a Ph.D. (1995) and M.S. (1991) in Mechanical Engineering from the University of Minnesota, and a B.S. (1987) from the University of Waterloo. Key research interests include atmospheric aerosol sources and processing, new particle formation via homogeneous nucleation, and aerosol growth processes. He develops novel instrumentation, such as the Particle Into Liquid Sampler (PILS), and leads field studies like the ALPACA project in Fairbanks, Alaska. His work bridges laboratory experiments and real-world atmospheric measurements. Dr. Weber has received awards including the Cullen-Peck Faculty Fellow Award (2007), Whitby Award (2005), and NASA Global Change Fellowship. His recent publications (2024–2025) address biomass burning plumes, urban pollution dynamics, and aerosol chemistry in cold climates. He collaborates on global initiatives like the NASA Atmospheric Tomography (ATom) mission and FIREX-AQ campaigns. His lab (ES&T 2107/2115) focuses on aerosol optical properties, reactive oxygen species in particulate matter, and the health effects of pollution. Research highlights include quantifying sulfur chemistry in Fairbanks and assessing oxidative potential of PM2.5 in urban environments.
Megan L. Matthews is an Assistant Professor in the Department of Chemistry at the University of Pennsylvania, School of Arts & Sciences, where she leads an active research group focused on chemical biology and enzymology. Her lab develops innovative chemical proteomics technologies to uncover novel enzyme cofactors and regulatory post-translational modifications, particularly those involving reactive electrophiles, which cannot be predicted from genomic sequences. B.S. in Chemistry, Miami University (2005) Ph.D. in Chemistry, The Pennsylvania State University (2011) Postdoctoral Fellow, The Scripps Research Institute (2012–2017) Her research centers on the concept of the 'electrophilome'—a largely unexplored half of the reactive proteome. By designing 'reverse-polarity' chemical probes, her group enables the discovery of functionally significant electrophilic modifications in proteins, especially those involved in cancer and Alzheimer’s disease. These discoveries open new avenues for therapeutic intervention through covalent targeting. The recent publications demonstrate a consistent focus on enzyme mechanisms, cofactor discovery, and chemical probe development. Her work spans from fundamental enzymology (e.g., halogenases, ribonucleotide reductases) to applied chemical biology (e.g., hydrazine probes, chemoproteomic profiling). The keywords across her publications highlight emerging themes in metalloenzymes, radical chemistry, and covalent proteome mapping. Her scientific contributions have been recognized through prestigious fellowships, including the Merck Helen Hay Whitney Postdoctoral Fellowship. She has published in top-tier journals such as Nature , Nature Chemical Biology , and Journal of the American Chemical Society . Dr. Matthews advises graduate students and postdoctoral researchers in her lab, fostering a collaborative and inclusive environment. Her lab emphasizes the importance of diverse perspectives in scientific discovery. She has secured research funding to support projects in probe development, target characterization, and disease mechanism studies, particularly in neurodegenerative diseases and cancer. The Matthews Lab is actively engaged in advancing reverse-polarity activity-based protein profiling (RP-ABPP) for in vivo applications and inhibitor screening. The group collaborates with experts in structural biology, spectroscopy, and disease modeling to translate basic discoveries into therapeutic insights.
Thomas Lectka is the Jean and Norman Scowe Professor in the Department of Chemistry at Johns Hopkins University, where he has been a faculty member since 1994. His research focuses on synthetic and physical organic chemistry, particularly in the area of organofluorine chemistry. PhD, Cornell University Postdoctoral Fellow, Heidelberg (Alexander von Humboldt Fellow) Postdoctoral Fellow, Harvard University (NIH Fellow) Dr. Lectka's research is centered on developing novel synthetic methods, especially for fluorination, and understanding the physical organic principles underlying reactivity. His work spans radical fluorination , catalytic asymmetric synthesis , and the design of fluorinated bioactive molecules . Using a combination of experimental and computational techniques, his lab investigates C-F bond formation , reaction mechanisms , and the biological applications of fluorinated compounds. His recent work, as reflected in publications from 2010 to 2024, shows a consistent trajectory in advancing fluorination methodologies, with increasing emphasis on site-selectivity , enantiocontrol , and biomedical relevance . Themes include the development of new reagents, mechanistic studies, and the synthesis of fluorinated natural product analogs and peptidomimetics. Dr. Lectka has received numerous honors and awards, including: ACS Arthur C. Cope Scholar (2024) ACS Maryland Chemist of the Year (2017) John Simon Guggenheim Memorial Fellowship Dreyfus Teacher-Scholar Award Sloan Fellowship NSF CAREER Award NIH First Award Eli Lilly Grantee Award He actively mentors graduate and undergraduate students in his research group, contributing to education and training in organic chemistry. His lab, The Lectka Group , is supported by grants from the NIH and NSF, enabling cutting-edge research in synthetic methodology and physical organic studies. The group fosters a collaborative environment focused on innovation in fluorine chemistry. The Lectka Group is an active research laboratory at Johns Hopkins University dedicated to pushing the boundaries of synthetic organic chemistry through the exploration of fluorine's unique properties. Current projects include site-selective radical fluorination and the synthesis of unusual fluorinated species, aiming to provide new tools for drug discovery and materials science.
Sveinung Sandberg is a Professor at the Department of Criminology and Sociology of Law, University of Oslo. His research spans marginalization, illegal drug markets, radicalization, and narrative criminology, combining theoretical frameworks from Bourdieu and narrative analysis. Academic Interests: Marginalisation, Legal & Illegal Drugs, Violence, Radicalization, Bourdieusian Criminology, Narrative Criminology, Latin American Studies, Social Movements Education: PhD from University of Bergen Research Focus includes: Street capital theory in criminology Drug market cultural dynamics Narrative approaches to extremism Latin American criminal trajectories Recent Publications examine pandemic-related crime shifts, gendered drug use patterns, and narrative mechanisms in criminal justice. His 2021-2025 projects Radicalization and Resistance and Crime in Latin America (CRIMLA) involve cross-country life-story analyses. Scientific Awards: Fridtjof Nansen's Award for Young Researchers (2011) The Meltzer Prize for Young Researchers (2010) Editorial Roles include board memberships at Theoretical Criminology , Deviant Behavior , and International Criminal Justice Review . He has conducted fieldwork in Mexico and held visiting positions at institutions including CIDE (Mexico City) and European Monitoring Centre for Drugs and Drug Addiction (Lisbon).
Tobias Dick serves as Professor and Head of the Division of Redox Regulation at the German Cancer Research Center (DKFZ) in Heidelberg, maintaining a primary affiliation with Heidelberg University's Faculty of Biosciences. His leadership spans molecular switch research within the SFB/TRR186 consortium focusing on spatio-temporal control of cellular signal transmission. Academic Background: PhD in Biochemistry, Freie Universität Berlin (1997, summa cum laude) Habilitation in Biochemistry, Heidelberg University (2009) Diploma thesis at German Cancer Research Center (1994) Study program in Biochemistry, Freie Universität Berlin (1989-1994) Research Focus: Dick pioneers investigations into thiol-based redox switches governing cellular signal transduction. His work establishes fundamental mechanisms of peroxiredoxin-mediated hydrogen peroxide signaling, protein persulfidation dynamics, and sulfur-based radical scavenging systems. Key contributions include developing real-time imaging probes for redox species and elucidating redox relays connecting peroxiredoxins to transcription factors like STAT3. Current research explores hydropersulfide protection against ferroptosis and metabolic adaptation through redox-sensitive enzymes. Publication Trends: Over 15 years of high-impact publications reveal an evolutionary trajectory from foundational redox imaging techniques (2008-2011) to sophisticated molecular mechanism studies (2013-2020), culminating in recent breakthroughs on sulfur signaling in cell death pathways (2023). His work consistently appears in premier journals like Nature Chemical Biology , demonstrating sustained innovation in redox biology methodology and conceptual frameworks. Scientific Recognition: ERC Advanced Grant (2017) Society for Free Radical Research Europe Basic Science Award (2017) Chica- and Heinz-Schaller-Award for young scientists (2009) Marie Curie Excellence Grant (2004) DFG Postdoctoral Fellowship (1998-2000) Studienstiftung des Deutschen Volkes Scholarship (1989-1994) Leadership & Mentorship: As founding vice-coordinator of DFG priority program SPP1710 (2014-present) and GBM Redox Biology Study Group (2011-2017), Dick shapes national research agendas. His division at DKFZ mentors next-generation scientists through ERC and DFG-funded projects, with trainees contributing to landmark publications on redox switches and cellular physiology. Research Infrastructure: The Division of Redox Regulation operates within DKFZ's state-of-the-art facilities, collaborating extensively through the SFB/TRR186 consortium. This environment enables cutting-edge investigations into redox-controlled cellular processes using advanced biochemical, imaging, and computational approaches.
Dr. Anouk Smeekes is an Associate Professor at Utrecht University's Department of Interdisciplinary Social Science, within the Faculty of Social and Behavioural Sciences. She leads research in the Youth Studies chairgroup, focusing on youth responses to societal challenges like climate change, populism, and colonial legacies. Her teaching spans the MERM Research Master (Ethnic Prejudice course), YDSC Master (thesis coordination), and ISS bachelor programs, while also serving on the Faculty's Exam Committee. Her research explores social/political psychology mechanisms through thematic pillars: Emotional responses of youth to societal disruptions National nostalgia's role in shaping political attitudes Intergroup relations in multicultural societies Climate anxiety and civic engagement pathways Recent publications demonstrate strong emphasis on collective nostalgia, identity politics, and youth psychology. Works frequently examine how historical narratives influence contemporary intergroup conflicts and radicalization, with increasing focus on climate-related anxieties (2020-2024). Methodologically, she employs cross-cultural comparisons across 27+ countries. Awards & Recognition: Rae and Dr. Dan Landis Outstanding Dissertation Award (2015) Research Leadership: CONCILIARE Horizon Europe project co-leader (2024-2027): Examining Europe's colonial heritage transitions Principal investigator: Youth climate anxiety/hope dynamics study (Faculty-funded) Supervises 10+ Master's theses annually in Migration/Ethnic Relations programs
Dr. William Unsworth is a Senior Lecturer in the Department of Chemistry at the University of York. He holds a Leverhulme Trust Early Career Fellowship and the inaugural Eleanor Dodson Fellowship. His research focuses on developing new methods for synthesizing functionalized macrocycles, spirocycles, heterocycles, and natural products, with key interests in ring expansion strategies (e.g., SuRE methodology), photochemistry, catalysis, and spirocyclization reactions. Education: Bachelor's and PhD in Chemistry from the University of Oxford (PhD under Prof. Jeremy Robertson, 2010) Postdoctoral Research Associate with Prof. Richard J.K. Taylor at the University of York (2010–2013) Research Interests: Macrocycle synthesis, medium-sized rings, cascade reactions, photochemical radical processes, and catalyst-driven scaffold diversity. His group’s work emphasizes practical applications in medicinal chemistry and drug discovery. Awards: Thieme Chemistry Journals Award (2020) RSC Hickinbottom Award (2018) European Lead Factory Chemical Library Creativity Award (2017) RSC/BMOS Young Investigator Award (2015) Grants and Projects: Leads initiatives like the ‘Macrocycles for Drug Discovery (MC4DD)’ project funded by the European Commission, and collaborates on projects involving biocatalysis and natural product synthesis. Labs/Teams: The Unsworth Research Group at the University of York includes collaborators like Prof. Richard Taylor and Prof. Gideon Grogan, focusing on interdisciplinary synthetic chemistry and sustainable methods.
Geoffrey Tranmer is a Tenured Associate Professor in the College of Pharmacy at the University of Manitoba. His research integrates medicinal chemistry, drug discovery, and synthetic organic methodologies, with a focus on flow chemistry and targeted cancer therapies. NSERC Post-Doctoral Fellow, University of Cambridge Post-Doctoral Fellow, Princeton University PhD in Organic Chemistry, University of Guelph BSc (Hons) in Chemistry, Brock University His research explores: Development of flow chemistry techniques to enhance synthetic organic methods Lead generation and optimization in drug discovery Bioconjugation strategies for chemical biology applications Targeted cancer therapies leveraging hypoxia-activated prodrugs Recent publications highlight his work in neurodegenerative disease drug design, biomarker discovery, and sustainable synthesis technologies. Scientific Awards CIHR Project Grant (2024-2029) NSERC Discovery Grant (2023-2028) CIHR Bridge Grant (2022) NSERC Alliance Grant (2020) NSERC Engage Grant (2017) Research Manitoba New Investigator Operating Grant (2017) Dr. Tranmer's industrial experience at Merck Frosst and academic leadership at Manitoba position him uniquely to bridge chemistry-biology-industry collaborations. His lab actively trains graduate students in cutting-edge synthesis platforms.
